veligrotug   Click here for help

GtoPdb Ligand ID: 14572

Synonyms: AVE-1642 | AVE1642 | Lumvoa®: | veligrotug-vvze | VRDN-001
Approved drug Immunopharmacology Ligand
veligrotug is an approved drug
Compound class: Antibody
Comment: Veligrotug (AVE-1642) is a monoclonal antibody that targets insulin-like growth factor 1 receptor (IGF1R) [4].
Click here for help
Immunopharmacology Comments
In autoimmune thyroid eye didease IGF1R overexpression triggers inflammation, cell proliferation, and hyaluronan accumulation in orbital fibroblasts and fat tissues [1,6,9]. Blocking IGF1R/TSHR cross-talk is proposed to target this pathology [5,11].